KINICITI
KINICITI invests in non-therapeutic companies enhancing cell and gene therapy innovation, providing them with capital, expertise, and strategic resources to accelerate their growth and impact.
Services
KINICITI empowers partner companies with resources, expertise, and capital to accelerate the advancement and adoption of cell and gene therapies. Their approach focuses on building strategic partnerships that maximize the potential from a vibrant scientific and business ecosystem. KINICITI’s flexible investment model ensures that companies supporting cell and gene therapeutics have access to the necessary capital and resources to bring these therapies to patients efficiently.
Sector
KINICITI operates in the cell and gene therapy industry, focusing on the innovation and development of non-therapeutic technologies that support these advanced treatment options. The company invests in startups and emerging companies with transformational capabilities in areas like cell engineering and gene-editing, cell sources, process science and scale-up tools, production technologies, and source-to-patient delivery systems.
Investment Strategy
KINICITI’s investment strategy is centered around transformational capabilities in the cell and gene therapy sector. They target companies with strong potential to leverage technology and operational capabilities to effect significant change. In alignment with their strategy, KINICITI has secured an additional commitment of $250 million from Welsh, Carson, Anderson & Stowe. These funds are aimed at bolstering companies that innovate in process science, production technologies, and other critical support systems for cell and gene therapies.
Capital and Partnerships
KINICITI raised additional capital from Biospring Partners to extend its global platform dedicated to the cell and gene therapy industry. This investment allows KINICITI to further its mission by nurturing partnerships that drive innovation and operational excellence. The commitment from Welsh, Carson, Anderson & Stowe provides a robust financial foundation to invest in companies that can offer significant technological advancements in the field.
Mission and Vision
KINICITI is committed to ensuring the promise of cell and gene therapies is delivered to patients in need by investing in and supporting companies with the capacity to drive transformational change. Their mission is to empower these companies through strategic resources, expertise, and capital, fostering an innovative ecosystem that accelerates the development and adoption of novel therapies.